Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - sodium amidotrizoate, quantity: 100 mg/ml; amidotrizoate meglumine, quantity: 660 mg/ml - injection, solution - excipient ingredients: water for injections; disodium edetate - intravenous and retrograde urography. computerised tomography. also for all angiographic examinations as well as for amniography, arthrography, intraoperative cholangiography, fistulography, hysterosalpingography, splenoportography, vesiculography and others. urografin is not to be used for myelography, ventriculography or cisternography since it is likely to provoke neurotoxic symptoms in the examinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - amidotrizoate meglumine, quantity: 260 mg/ml; sodium amidotrizoate, quantity: 40 mg/ml - injection, intravenous infusion - excipient ingredients: sodium calcium edetate; water for injections - intravenous and retrograde urography. computerized tomography. also for all angiographic examinations as well as for aminography, arthrography, intraoperative cholangiography, fistulography, hysterosalpingography, splenoportography, vesiculography and others. urografin is not to be used for myelography, ventriculography of cisternography, since it is likely to provoke neurotoxic symptoms in these examinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - sodium amidotrizoate, quantity: 40 mg/ml; amidotrizoate meglumine, quantity: 260 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate - intravenous and retrograde urography. computerized tomography. also for all angiographic examinations as well as for aminography, arthrography, intraoperative cholangiography, fistulography, hysterosalpingography, splenoportography, vesiculography and others. urografin is not to be used for myelography, ventriculography of cisternography, since it is likely to provoke neurotoxic symptoms in these examinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - amidotrizoate meglumine, quantity: 660 mg/ml; sodium amidotrizoate, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; water for injections - intravenous and retrograde urography. computerized tomography. also for all angiographic examinations as well as for aminography, arthrography, intraoperative cholangiography, fistulography, hysterosalpingography, splenoportography, vesiculography and others. urografin is not to be used for myelography, ventriculography of cisternography, since it is likely to provoke neurotoxic symptoms in these examinations.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - meglumine amidotrizoate 660 mg/ml (formed from meglumine and amidotrizoic acid); sodium amidotrizoate 100 mg/ml (formed from sodium hydroxide and amidotrizoic acid) - solution for infusion - 76 % - active: meglumine amidotrizoate 660 mg/ml (formed from meglumine and amidotrizoic acid) sodium amidotrizoate 100 mg/ml (formed from sodium hydroxide and amidotrizoic acid) excipient: sodium calcium edetate water for injection - intravenous and retrograde urography. also for all angiographic examinations as well as for amniography, arthrography, intraoperative cholangiography, endoscopic retrograde cholangiopancreatography (ercp), sialography, fistulography, hysterosalpingography, splenoportography, vesiculography and others. urografin is not to be used for myelography, ventriculography or cisternography, since it is likely to provoke neurotoxic symptoms in these examinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - sodium diatrizoate; meglumine diatrizoate -

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - meglumine amidotrizoate 260 mg/ml (formed from melgumine and amidotrizoic acid); sodium amidotrizoate 40 mg/ml (formed from sodium hydroxide and amidotrizoic acid) - solution for infusion - 30 % - active: meglumine amidotrizoate 260 mg/ml (formed from melgumine and amidotrizoic acid) sodium amidotrizoate 40 mg/ml (formed from sodium hydroxide and amidotrizoic acid) excipient: sodium calcium edetate water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - meglumine; sodium hydroxide ; sodium amidotrizoate - solution for infusion - 30 percent weight/volume - diatrizoic acid

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - meglumine amidotrizoate; sodium amidotrizoate - solution for injection - 260mg/1ml ; 40mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - sodium amidotrizoate; meglumine amidotrizoate - solution for injection - 40mg/1ml ; 260mg/1ml